SYRA HEALTH CORP. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
EPS (Diluted)
$-0
Book Value Per Share
$0
Free Cash Flow Per Share
$-0
Cash Per Share
$0
Revenue Per Share
$1
OCF Per Share
$-0
Return on Equity
-36.0%
Return on Assets
-27.8%
Return on Invested Capital
-28.7%
Current Ratio
4.06
Quick Ratio
4.06
Asset Turnover
2.24
Days Sales Outstanding
46.39
Days Payables Outstanding
5.86
R&D / Revenue
0.9%
SBC / Revenue
1.4%
Capex / Revenue
0.0%
Working Capital
$2M
Net Current Asset Value
$2M
Invested Capital
$2M
OCF / Net Income
0.50
FCF / Net Income
0.50
Accruals Ratio (Sloan)
-16.2%
Net Debt
$-2M
Net Debt / EBITDA
1.83
Interest Coverage
-68.15
Cash Coverage
-33.74
Capex Coverage
-4184.54
Tangible Common Equity
$2M
TCE / Total Assets
75.7%
NOPAT
$-714K
Cash ROIC
-18.0%
WC / Revenue
28.6%
Capex / D&A
0.01
Reinvestment Rate
2.3%
Asset Growth vs Revenue Growth
-15.2%
Stock Price (FY-end)
$0
Market Cap
$1M
P/S Ratio
0.14
P/B Ratio
0.49
P/TB Ratio
0.49
Enterprise Value
$-595K
EV / Sales
-0.08
FCF Yield
-43.9%
Shareholder Yield
-9.7%
R&D Yield
6.7%
Capex Yield
0.0%
Shares Variation (YoY)
57.0%
Beta (5Y)
1.01
Cost of Equity
9.5%
52W High
$1
52W Low
$0
Trailing Return 1Y
-80.8%
F-Score (Piotroski)
4.00
Z-Score (Altman)
-1.58
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.